
Herceptin patents survive preliminary non-infringement challenge under new rules
Tuesday, October 23, 2018 @ 1:57 PM | By Andrew McIntosh
Significant amendments to the Patented Medicines (Notice of Compliance) Regulations came into force in September 2017. A purpose of these Regulations is to ensure that manufacturers of generic or biosimilar medicines...